Trials / Terminated
TerminatedNCT00484146
Alterations of Immunologic Mediators During Severe Sepsis
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Klinikum St. Georg gGmbH · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Severe sepsis induces significant changes in expression of insulin- and toll-like receptors, cytokines, markers of apoptosis, and activation of t- and b-lymphocytes.
Detailed description
In patients at early stage of severe sepsis, we investigate the expression of pro- and anti-inflammatory cytokines, chemokines, adhesion-molecules, toll-like receptors, insulin-receptors, markers of apoptosis und of t- and b-cell-activation on a mRNA level.
Conditions
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2007-06-08
- Last updated
- 2017-02-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00484146. Inclusion in this directory is not an endorsement.